Maitreya Medicare (NSE:MAITREYA) Change In Receivables: ₹-51.1 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹118.30
View Full Analysis

What is Maitreya Medicare Change In Receivables?

Maitreya Medicare NSE:MAITREYA +4.05% 18 Change In Receivables is ₹-51.1 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Maitreya Medicare's change in receivables for the quarter that ended in Sep. 2023 was ₹-51.1 Mil. It means Maitreya Medicare's Accounts Receivable increased by ₹51.1 Mil from Mar. 2023 to Sep. 2023 .

Maitreya Medicare's change in receivables for the fiscal year that ended in Mar. 2023 was ₹-38.5 Mil. It means Maitreya Medicare's Accounts Receivable increased by ₹38.5 Mil from Mar. 2022 to Mar. 2023 .

Maitreya Medicare's Accounts Receivable for the quarter that ended in Sep. 2023 was ₹150.4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Maitreya Medicare's Days Sales Outstanding for the six months ended in Sep. 2023 was 110.70.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Maitreya Medicare's liquidation value for the six months ended in Sep. 2023 was ₹-0.9 Mil.

Maitreya Medicare  (NSE:MAITREYA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Maitreya Medicare's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=150.39/247.936*91
=110.70

2. In Ben Graham's calculation of liquidation value, Maitreya Medicare's accounts receivable are only considered to be worth 75% of book value:

Maitreya Medicare's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=16.834-133.09+0.75 * 150.39+0.5 * 5.091
=-0.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Change In Receivables Related Terms

Maitreya Medicare Change In Receivables Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Change In Receivables Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Change In Receivables
-44.44 -12.88 -38.50

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Change In Receivables 0.00 0.00 0.00 -51.10
NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-51.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of ₹-51.1 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Change In Receivables of ₹-51.1 Mil as of Sep. 2023. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Maitreya Medicare and its competitors.
Is Maitreya Medicare's Change In Receivables too high?
Maitreya Medicare's current Change In Receivables is ₹-51.1 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Change In Receivables compare to HCA and DVA?
Maitreya Medicare's Change In Receivables of ₹-51.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Maitreya Medicare and its competitors. Maitreya Medicare's current Change In Receivables is ₹-51.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Change In Receivables of ₹-51.1 Mil. The current Change In Receivables is ₹-51.1 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Change In Receivables is ₹-51.1 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹118.30
Price